Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $110.5200 (-0.99%) ($109.4800 - $111.5600) on Fri. Jan. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.74% (three month average) | RSI | 73 | Latest Price | $110.5200(-0.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.6% a day on average for past five trading days. | Weekly Trend | ABBV advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(45%) SPLV(36%) VYM(33%) XLP(33%) DIA(32%) | Factors Impacting ABBV price | ABBV will decline at least -0.87% in a week (0% probabilities). VIXM(-23%) UUP(-9%) VXX(-4%) IGOV(-2%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.87% (StdDev 1.74%) | Hourly BBV | -0.9 () | Intraday Trend | -0.6% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $110.68(-0.14%) | 10 Day Moving Average | $108.63(1.74%) | 20 Day Moving Average | $106.55(3.73%) | To recent high | -1.7% | To recent low | 37.3% | Market Cap | $194.989b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |